Table 3.

Antithrombotic use at cardiac implantable electronic device procedure

Antithrombotic	No AP (N = 2691 [39.6%])	AP (N = 4109 [60.4%])
No AC	972 (14.3%)	2860 (42.1%)
AC	1719 (25.3%)	1249 (18.4%)
Warfarin	1067 (62.1%)	738 (59.1%)
DOAC	455 (26.5%)	312 (25.0%)
Unknown AC type	197 (11.5%)	199 (15.9%)
AC strategy
Uninterrupted	675 (39.3%)	449 (35.9%)
Interrupted	874 (50.8%)	612 (49.0%)
Bridging	64 (3.7%)	49 (3.9%)
Unknown AC strategy	106 (6.2%)	139 (11.1%)

Data are reported as n (%).

AC = anticoagulant; AP = antiplatelet; DOAC = direct oral anticoagulant.